Adams v. Mass General Brigham Incorporated

CourtDistrict Court, D. Massachusetts
DecidedNovember 10, 2021
Docket1:21-cv-11686
StatusUnknown

This text of Adams v. Mass General Brigham Incorporated (Adams v. Mass General Brigham Incorporated) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Adams v. Mass General Brigham Incorporated, (D. Mass. 2021).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

_______________________________________ ) TOGETHER EMPLOYEES, by ) individual representatives, ROBERTA ) LANCIONE, JOYCE MILLER, MARIA ) DIFRONZO, MICHAEL SACCOCCIO, ) ELIZABETH BIGGER, NATASHA ) DICICCO, NICHOLAS ARNO, and ) RUBEN ALMEIDA, ) ) Civil Action No. Plaintiffs, ) 21-11686-FDS ) v. ) ) MASS GENERAL BRIGHAM ) INCORPORATED, ) ) Defendant. ) _______________________________________)

MEMORANDUM AND ORDER ON PLAINTIFFS’ MOTION FOR PRELIMINARY INJUNCTION SAYLOR, C.J. This is a case challenging a mandatory COVID-19 vaccination policy. Defendant Mass General Brigham, Inc. (“MGB”) is a Massachusetts corporation and major hospital and healthcare network that operates, among other facilities, Massachusetts General Hospital and Brigham and Women’s Hospital in Boston. Plaintiff Together Employees is an unincorporated association of 229 employees of MGB who were denied a religious or medical exemption from a COVID-19 vaccination policy. The remaining plaintiffs are eight individual employees whose exemption requests were denied. On June 24, 2021, MGB announced a mandatory COVID-19 vaccination policy for all its employees. It later set a deadline for that policy, providing that non-complying employees would be placed on unpaid leave on October 20, 2021, and thereafter terminated on November 5, 2021. On October 17, 2021, plaintiffs brought this lawsuit, alleging claims of discrimination and retaliation under Title VII and the ADA and seeking to enjoin MGB from enforcing its

vaccination policy. The Court held hearings on plaintiffs’ motion for preliminary injunction on October 20 and November 4, 2021, and orally denied the motion from the bench. The following memorandum sets forth the reasoning of the Court in greater detail. I. Background Except where noted, the Court relies on the parties’ briefs, affidavits, documentary evidence, and oral argument to decide the present motion. A. Factual Background Plaintiff Together Employees is an unincorporated association of 229 employees who were denied a religious or medical exemption from the MGB COVID-19 vaccination policy. The remaining plaintiffs are individual employees of MGB who were denied religious or medical accommodations. (Pl. Exs. J-M; O-R).1

Defendant Mass General Brigham, Inc. is a Massachusetts corporation with a principal place of business in Massachusetts. MGB owns and operates hospitals and other facilities throughout the Commonwealth of Massachusetts. (Klompas Dec. ¶¶ 5-7). Among other things, it owns and operates Massachusetts General Hospital; Brigham and Women’s Hospital; Faulkner Hospital; McLean Hospital; Massachusetts Eye and Ear Hospital; Newton-Wellesley Hospital; Cooley Dickinson Hospital; and Spaulding Rehabilitation Hospital. Each year, MGB provides

1 Plaintiffs’ exhibits are designated as Exhibits A-S with the complaint; Exhibits A-B with the motion for preliminary injunction; and Exhibits 1-19 filed separately. Because the two exhibits attached to the motion for preliminary injunction are not referenced in this opinion, the Court will refer to plaintiffs’ Exhibits A-S and 1-19 where relevant. medical care for 1.5 million patients. (Id. ¶ 6). 1. COVID-19 Pandemic COVID-19 is a contagious viral disease that can cause serious illness and death. (Id. ¶ 19). As of this writing, approximately 750,000 Americans have died from the disease. CTR. FOR DISEASE CONTROL & PREVENTION, COVID-19 MORTALITY OVERVIEW: PROVISIONAL DEATH

COUNTS FOR CORONAVIRUS DISEASE 2019 (2021) (last updated Nov. 3, 2021). In the summer of 2021, after several months of declining infection rate, the highly contagious Delta variant of the virus caused a significant further outbreak. In 2020 and early 2021, three COVID-19 vaccines were approved by the Food and Drug Administration as safe and effective. The three vaccines were developed and produced by Pfizer, Moderna, and Johnson & Johnson. U.S. FOOD & DRUG ADMIN., COVID-19 VACCINES (2021) (last updated Oct. 29, 2021). The Pfizer and Moderna vaccines employ messenger RNA (mRNA) technology; the Johnson & Johnson does not. (See id.). Both the federal and Massachusetts state governments prioritized the early vaccination of all hospital workers, recognizing the importance of protecting the healthcare workforce during the pandemic.

(Klompas Dec. ¶ 25). 2. MGB’s COVID-19 Vaccination Policy In June 2021, MGB announced it would require its employees to obtain a COVID-19 vaccination. (Pl. Ex. A). In light of the outbreak of COVID-19 caused by the Delta variant, MGB determined that such a vaccination policy was critical to keeping safe its medically vulnerable patient population, employees, and visitors. (Klompas Dec. ¶¶ 20-21, 27). MGB required that employees receive the COVID-19 vaccine by October 15, 2021. (Id. ¶ 13). Employees were told that noncompliance with the policy would result in unpaid leave, and ultimately, termination. The announcement also explained that certain exemptions would be available for medical or religious reasons. (Id.). Employees seeking a religious exemption were required to fill out an online form. (Id.). The form asked several questions and contained a text box stating: In the space provided, please (1) identify your sincerely held religious belief, practice or observance and (2) explain why it prevents you from receiving a COVID-19 vaccine. Please note that you may be required to provide additional information or supporting documentation to support your request for an exemption.

(Pl. Ex. C). The online form did not provide an option to attach supporting documentation. However, the text box response field did not have a character limit, and the instructions noted that “the text box would expand as needed.” (Nichols Dec. ¶ 9). The online form advised employees that they “may be required to provide additional information or supporting documentation to support [their] request for an exemption.” (Id. ¶ 8). Employees seeking a medical exemption were provided a form to be completed by a physician. (Hashimoto Dec. ¶ 6). The exemption form contained several check boxes to be filled by the employee’s physician to indicate whether the employee had one of several conditions indicated by the Centers for Disease Control (CDC) that might merit a deferral of vaccination. (Id. ¶ 7). One of the check boxes asked the physician to identify “other medical reasons,” and instructed the physician to explain his or her reasoning elsewhere on the form. (Id. ¶ 11). MGB created two separate committees to review requests for exemption. The first committee, the Religious Exemption Review Committee, was “led by a senior attorney in MGB’s Office of the General Counsel and comprised of trained Human Resources professionals.” (Nichols Dep. ¶¶ 11, 19). The members of the committee were “trained in responding to accommodation requests and given additional training in responding to religious exemption requests.” (Id. ¶¶ 10, 19). Employees who raised “substantive religious objection[s]” to the vaccination policy received follow-up questions from the committee, often individualized to the particular objection of the employee. (Id. ¶¶ 25-28). Employees who received follow-up questions were directed to send their responses to a dedicated MGB e-mail box and were free to

submit whatever supporting documentation they wanted. (Id. ¶ 29). In some cases, the committee sent additional follow-up questions to employees after determining more information was needed. (Id. ¶ 31). The second committee, the Medical Exemption Review Committee, was directed by Dr. Dean Hashimoto, the Chief Medical Officer for Workplace Health and Wellness. (Hashimoto Dec. ¶ 3). MGB assembled two panels to review these requests: one focused on occupational health, and the other focused on infection control. (Id. ¶¶ 13-15).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Yakus v. United States
321 U.S. 414 (Supreme Court, 1944)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Trans World Airlines, Inc. v. Hardison
432 U.S. 63 (Supreme Court, 1977)
Ansonia Board of Education v. Philbrook
479 U.S. 60 (Supreme Court, 1986)
School Bd. of Nassau Cty. v. Arline
480 U.S. 273 (Supreme Court, 1987)
Edelman v. Lynchburg College
535 U.S. 106 (Supreme Court, 2002)
US Airways, Inc. v. Barnett
535 U.S. 391 (Supreme Court, 2002)
Munaf v. Geren
553 U.S. 674 (Supreme Court, 2008)
DeNovellis v. Shalala
135 F.3d 58 (First Circuit, 1998)
Higgins v. New Balance Athletic Shoe, Inc.
194 F.3d 252 (First Circuit, 1999)
Bonilla v. Muebles J.J. Alvarez, Inc.
194 F.3d 275 (First Circuit, 1999)
Griel v. Franklin Medical Center
234 F.3d 731 (First Circuit, 2000)
Reed v. Lepage Bakeries, Inc.
244 F.3d 254 (First Circuit, 2001)
Lebron-Torres v. Whitehall Laboratories
251 F.3d 236 (First Circuit, 2001)
Navarro Pomares v. Pfizer Corporation
261 F.3d 90 (First Circuit, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
Adams v. Mass General Brigham Incorporated, Counsel Stack Legal Research, https://law.counselstack.com/opinion/adams-v-mass-general-brigham-incorporated-mad-2021.